NCAM1 and Miyoshi myopathy: Although the proportion of NK cells is unaltered during progression from MGUS to SMM and MM, immunophenotypic differences in NK cells are observed; significantly lower proportions of CD57–CD56+ and CD57–CD16+ lymphocyte subsets are observed in patients with MM than in those with MGUS [23].